John Northcott Biography and Net Worth

John Northcott joined Nektar in December 2019 as Senior Vice President and Chief Commercial Officer to lead commercial strategy, marketing, sales, analytics, commercial operations, and market access functions for the company. Mr. Northcott brings extensive commercial experience to Nektar, including both pre-launch planning and commercialization in oncology and other therapeutic areas. Most recently, John served as the Chief Commercial Officer of Pharmacyclics from 2015 to 2019, where he led all commercial functions for Imbruvica^® (ibrutinib).

From 2013 to 2015, Mr. Northcott was Chief Commercial Officer at Lexicon Pharmaceuticals where he led commercial strategy and operations for all products and therapeutic areas. From 2007 to 2013, he held commercial roles in both U.S. and Global marketing for Avastin^® (bevacizumab) with Genentech and the Roche Group, having most recently served as International Business Leader for Avastin, leading global product strategy initiatives in oncology. Prior to his time at Roche/Genentech, Mr. Northcott held management positions in sales and marketing in a variety of therapeutic areas at other pharmaceutical companies including Merck and Pfizer.

Mr. Northcott holds a B.A. degree in Business Administration from St. Francis Xavier University.